Introducing Glyteine to the world under the Continual-G brand Now after a 20-year process, we have the infrastructure in place and we can offer the world GGC-containing products under the Continual-G brand, says Steven Baldini
Several randomized controlled trials tested oral glutathione at 250-500 mg daily
Those target genes include heme oxygenase 1 (HMOX-1), the main regulator of iron and heme metabolism (Suzen et al., 2022), NAD(P)H quinone dehydrogenase 1 (NQO-1), a reducer of ROS (quinones) (Ross and Siegel, 2021), and peroxiredoxin (PRX), which reduces peroxides (Chowdhury et al., 2009), among many others
Journal of Agricultural and Food Chemistry, 62 , 9499-9506
*Correspondence: Peng Xu, [email protected] ORCID: Lin Liu, Jiachen Wang, Weikun Hou, This article was submitted to Molecular Diagnostics and Therapeutics, a section of the journal Frontiers in Molecular Biosciences Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
